NYSE:TAK
Takeda Pharmaceutical Company Limited Stock News
$13.22
-0.0900 (-0.676%)
At Close: May 17, 2024
TOKYO , April 22, 2024 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK, President and CEO; Christophe Weber, "Takeda"), Astellas Pharma Inc. (TSE: 4503, President and CEO: N
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) adm
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced the selection of eight new U.S. non-profit organizations as grant recipients, as part of its $14.6 million commitment to i
Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE
08:53am, Wednesday, 27'th Mar 2024
Takeda's 'In Their Shoes' initiative illuminates the daily struggles of IBD patients in the UAE, fostering empathy and understanding among participants. DUBAI, UAE, March 27, 2024 /PRNewswire/ --
2 More Potential Biotech Buyout Targets
01:07pm, Monday, 25'th Mar 2024
M&A activity in the biotech/biopharma sector is expected to remain active due to significant cash on Big Pharma's balance sheets, key patent expirations, and declining revenue from Covid related produ
Newer Treatments In Alpha-1 Antitrypsin Deficiency: $2.5 Billion/Year Market Size By 2032
05:34pm, Thursday, 14'th Mar 2024
Alpha-1 antitrypsin deficiency, or AATD, is an inherited disease that affects the lung, liver, and skin. The current treatment landscape involves smoking cessation, COPD treatment, and augmentation th
Takeda Pharmaceutical Co. (TAK) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Monday, 11'th Mar 2024
Takeda Pharmaceutical Co. (TAK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
TAK or STVN: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 11'th Mar 2024
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Takeda Pharmaceutical Co. (TAK) and Stevanato Group (STVN). But which of these two stocks is more attracti
Japan's Takeda partners with India's Biological E. to boost dengue vaccine production
01:07am, Tuesday, 27'th Feb 2024
Japan's Takeda Pharmaceutical will scale up production of its dengue vaccine Qdenga through a partnership with Indian vaccines maker Biological E., the companies said on Tuesday.
US FDA approves Takeda's therapy for allergic inflammation in esophagus
08:13am, Monday, 12'th Feb 2024
Drugmaker Takeda said on Monday the U.S. Food and Drug Administration has approved its therapy for a type of allergic inflammation of the esophagus, making it the first oral treatment for the conditio
Takeda Pharmaceutical Company Limited (TAK) Q3 2023 Earnings Call Transcript
02:15pm, Friday, 02'nd Feb 2024
Takeda Pharmaceutical Company Limited (TAK) Q3 2023 Earnings Call Transcript
3 Stocks to Buy to Benefit From the Booming Sleep Industry
02:30pm, Tuesday, 23'rd Jan 2024
Google “How important is sleep?” and you get three billion results.
One Ultra-Cheap High-Yield Dividend Stock to Buy
05:35am, Friday, 22'nd Dec 2023
Takeda Pharmaceutical is one of the top pharma companies in the world. It has a broad mix of products in its portfolio, which can provide investors with some stability.
Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?
11:17am, Thursday, 07'th Dec 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?
11:16am, Friday, 17'th Nov 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest